Note: Prelude's revenues are gauged from an analysis of company filings.
Prelude has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
July 27, 2018
Complete list of funding rounds and total amounts in the Company Report
Prelude's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Prelude Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Prelude is developing and marketing.
Prelude's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
DCISIONRT Medical, prognostic and predictive services being medical diagnosis and treatment in the field of oncology; medical testing services for diagnostic or treatment purposes, including molecular and genetic testing; and pathology services for diagnostic or treatment purposes in the field of oncology
Patent applications show Prelude's intellectual property,
its current capabilities and future direction.
Prelude has applied for 1 patents since 2009.
Prelude's most recent patent was filed in January 2012 for Cancer Biomarkers And Methods Of Use Thereof.Embodiments are provided for characterizing a biological sample. In some embodiments, one can estimate the risk that a subject with ductal carcinoma in situ will have a subsequent DCIS event and/or invasive cancers.
Complete list of patent applications
Determine whether Prelude grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Prelude is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Prelude vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Prelude, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Prelude and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.